COSMETICS & MEDICAL DEVICE DIVISION

Scientific ground for what your product promises

BiCT is the R&D partner of companies developing cosmetics and medical devices. We verify safety and efficacy on reconstructed human models in vitro, and we supply biotech ingredients of our own. Not isolated tests: the evidence it takes to bring a product to market and to defend it.

Let’s talk about your project
BiCT laboratory: assessment of a cosmetic product
THREE PATHS

Three paths, three ways of working with us

The starting point is not the test: it is the product in your hands and the decision you have to make.

If you develop finished cosmetics

Brands, contract manufacturers and formulation houses launching a new reference or strengthening the ones already in the catalogue. You need a product that holds up on the shelf and a dossier that holds up with the regulator.

What you need: safety assessment for the PIF · efficacy evidence on the finished product · benchmarking against reference products · scientific narrative for the sales force · support in choosing the actives.

If you develop medical devices

Products acting on mucosae — respiratory, oral, oesophageal, rectal — that fall under Regulation (EU) 2017/745, not 1223/2009. A different regulatory frame, different experimental models, a different vocabulary.

What you need: mucoadhesion and barrier effect · mucolytic and fluidifying action · cytoprotection on 3D reconstructed epithelium · cytotoxicity to ISO 10993-5 · evidence for the technical file.

If you produce ingredients

Manufacturers of actives and extracts who need to show what their raw material does, and to show it to whoever will formulate with it. A path we follow on request, covering testing and characterisation.

What you need: characterisation of biological activity · mechanism of action on 3D skin models · comparison with category references · data for the technical dossier addressed to your downstream customers.

A claim is not sustained by a promise

The cosmetics market is more crowded and more closely controlled than it used to be. Regulation 1223/2009 requires every label statement to be supported by documented evidence; buyers ask for data; consumers ask to understand.

Without credible models and data of its own, a product does not get selected, does not get defended and does not get recommended.

What we solve

From the problems clients bring us to the tests that close them: every project starts from a decision to be made, not from a catalogue code.

A claim you cannot support
In vitro efficacy testing on the right district — soothing, antioxidant, prebiotic, antimicrobial, antiviral, anti-glycation — with the method chosen to fit the promise you need to support, not the price list.
A dossier to close, and little time
The in vitro safety package: skin and eye irritation on reconstructed tissues following the OECD guidelines, MTT and NRU cytotoxicity, 3T3 phototoxicity, pro-sensitising potential, ISO 11930 challenge test and stability.
A product that looks like all the others
Comparative studies against reference products, experimental models built around your case and proprietary biotech ingredients: what makes the difference demonstrable instead of merely stated.
Doubt whether it is a cosmetic or a medical device
We place the promise in the right regulatory frame before it becomes a problem and, where needed, move the project onto the models and tests required by Regulation 2017/745.
HOW WE WORK

Reconstructed human models, no shortcuts

No animal testing: it has been banned for cosmetics in Europe since 2013, and the in vitro models we use today tell us more than it ever did. Over 200 studies carried out with these systems since 2018.

1

Reconstructed 3D skin and epithelia

Our reference model, and the one most used across the projects we run: reconstructed human epidermis and mucosae, where irritation, cytoprotection, barrier effect and the response to an active are observed on a stratified, viable tissue.

2

Cell cultures and microbiology

Keratinocytes and fibroblasts for mechanisms of action, and a broad strain collection for antimicrobial, anti-biofilm, antiviral and prebiotic activity — through to qPCR and metagenomics on swabs from your in vivo studies.

3

Chemistry and enzymology

Analytical method development, antioxidant capacity by the TEAC method, enzyme inhibition and AGE fluorescence measurement for anti-glycation: the assays that quantify what the cell models show.

Three biotech ingredients, ours

Developed and produced in house, with the evidence dossier already built. If you formulate a finished product you can start here, instead of hunting for an active that does what you need.

Lactive™Bioactivated lactoferrin releasing synergistic peptides: it acts selectively on skin pathogens, disrupts biofilm and triggers skin regeneration.
Evobiom™A postbiotic from L. rhamnosus for rebalancing the skin microbiome: it supports the recovery of sensitive, reactive skin.
ExoLife Rh™Extracellular vesicles from L. rhamnosus obtained by precision fermentation: microcirculation, barrier resilience, radiance.

Six concrete reasons, for R&D, Marketing and Regulatory

Studies do not end up in a report: they become arguments used inside the company and out on the market.

Close the dossier with your own datawithout depending on third-party literature or on supplier data
Support the claim on the labelwith the kind of evidence the Regulation expects
Differentiate the productwith comparative studies against category references
Give the sales force argumentsmaterial built for the people who have to explain the product
Shorten development timesin vitro screening before committing a pilot batch
Present to international buyerswith an orderly, traceable and verifiable dossier

Where do we start?

I am developing a finished cosmetic

I am developing a medical device

I am not sure where to begin

Frequently asked questions

Do you test on animals?

No: we work on reconstructed human tissues and cells, following OECD guidelines.

Which claims can you support?

Safety, anti-ageing, barrier and soothing, skin microbiome, tone and UV protection, on the finished product or on the ingredient.

Do you also work on medical devices?

Yes, on substance-based devices under Regulation (EU) 2017/745, district by district.

Our experience at the service of important projects.
The next one could be yours!

Being innovative means being passionate about evolving what already exists in order to improve it, bringing a valuable contribution to health, environment and sustainable development: let’s get in touch and find the best way to make the difference.

Contact us

Tell us about your project

Write to us here: the division team will get back to you.